When to take BPC-157: morning, night, or around training?
Reviewed 15 sourcesPublished by PepVault
No study has compared morning, night or training times for BPC-157. Here is the timing every study used, by species, and what its minutes-long half-life means.

- Last reviewed
- Sources
- 15
- Questions
- 7
- Compounds
- 1
The short answer
No study in any species has compared morning with night, or before with after training, for BPC-157, and it has no label because it is approved nowhere. The rat healing studies gave it once a day, the first dose right after the injury or 30 minutes later. Injected into a muscle in rats and dogs, it peaks within minutes and is gone from the blood by 4 hours.
Evidence: Animal research for every timing question, mostly in rats from one Zagreb group; in people, small uncontrolled reports, two placebo-controlled enema studies known from abstracts, and registered trials with no results yet; no study of time of day, food or training timing in any species.

Does the time of day matter for BPC-157?
Nobody has tested it. A drug's label is where timing rules usually come from, and BPC-157 has none: no regulator anywhere has approved it, so no label says morning, night or with food. Our PubMed search on November 20, 2026 for BPC-157 with circadian, time of day, exercise, training, fasting or meals found no study that compared two times of day or timed it around a workout, in rats, dogs or people.
PepVault keeps a dose time for each compound, and with its reminder on it nudges you when that time has passed and the dose is not logged yet. Set reminders in PepVault
What the studies do show is how fast it comes and goes. In a 2022 study in rats and beagle dogs, BPC-157 injected into a muscle reached its highest blood level 3 minutes later in rats and about 6 to 9 minutes later in dogs. Half of it was gone in under 30 minutes (its half-life, explained at pepvault.app/glossary/half-life), and none could be found 4 hours after the dose in either species8. Given daily for seven days, the blood curve looked almost the same as after a single dose, so it did not build up8.
Put that next to a clock and the morning-or-night question shrinks. In the rats and dogs measured, a morning dose and an evening dose would both leave the blood within a few hours, long before the next one. In the healing studies the rats got one dose a day and still healed better than untreated rats, so the effect in those studies did not depend on keeping a level in the blood around the clock.

What timing did the BPC-157 studies use?
Since there is no label, the studies are the only timing on record. Here is every schedule we could verify, with the species marked. The animal studies are from the Zagreb group that discovered BPC-157 unless the row says otherwise.
| Study | Species | Route | When it was given |
|---|---|---|---|
| Cut Achilles tendon, 20031 | Rats | Belly injection | Once a day, first dose 30 min after surgery, last 24 h before the end, up to 14 days |
| Cut knee ligament, 20102 | Rats | Belly injection, cream, drinking water | Injection or cream once a day from 30 min after surgery; water all day, through 90 days |
| Cut thigh muscle, 20063 | Rats | Belly injection | Once a day from 30 min after the cut, through 72 days |
| Crushed calf muscle, 20084 | Rats | Belly injection or cream | Right after the injury, then once a day for 14 days |
| Muscle-tendon junction, 20215 | Rats | Belly injection, drinking water | Injection right after surgery, then daily; or in the water, up to 42 days |
| Painkiller (diclofenac) damage, 20116 | Rats | Belly injection, drinking water | Right after each daily painkiller dose, or in the water, for 3 days |
| Head injury, 20107 | Mice | Belly injection | 30 min before, or just before, the injury |
| Blood levels, 2022, Xi'an8 | Rats, dogs | Into a muscle | Once, and once a day for 7 days |
| Safety study, 28 days, Xi'an12 | Rats, dogs | Into a muscle | Once a day for 28 days, then 14 days off |
| Knee pain, 2021912 | People, 17 (16 reached) | Into the knee | 1 or 2 injections, asked about months later |
| Bladder pain, 202410 | People, 12 | Into the bladder wall | Once, during one procedure |
| Drip into a vein, 202511 | People, 2 | Into a vein | Day 1 and day 2, each over one hour |
| Enema, healthy men, 2002-0312 | People, 24 on BPC-157 (8 on placebo) | Enema | One dose, a week off, then once a day for 7 days |
| Enema, ulcerative colitis, 200512 | People, 53 (half on placebo) | Enema | Once a day for 2 weeks |
| Tablet trial, registered 201513 | People, 42 planned | By mouth | One dose, then every 8 hours for 2 weeks; no results posted |
| Shoulder surgery trial, from 202714 | People, 30 planned | Under the skin | Once a day for 90 days after surgery |
| Gummy study, 202515 | People, 40 | By mouth | Two gummies a day for 8 weeks; no results posted |
Every animal row used amounts per kilogram of body weight in rats, mice or dogs. Those are lab schedules, not a plan for a person, and an effect in a rat is not proof of one in people. The published human rows are small reports with no comparison group; the two enema studies had a placebo group but are known only from meeting abstracts.
Is BPC-157 taken once or twice a day?
In the studies, almost always once. Every injected healing study in the table gave one dose a day12345, and so did the 28-day safety study12 and the planned shoulder trial14. The drinking-water studies are the exception in spirit: the rats sipped it all day, about 12 mL a day each25. The one human plan with several daily doses is the 2015 tablet trial, every 8 hours13, and it never posted results.
No study has put once a day against twice a day. The short half-life is the argument people make for splitting a dose, but the rats in the table healed on one dose a day even though it left their blood within hours8. Whether a split dose does more in a person is untested.
Should you take BPC-157 before or after training?
No study has timed BPC-157 to exercise in any species. The closest thing to a before-or-after test is about injuries, not workouts. In the healing studies, rats got the first dose 30 minutes after surgery or straight after a crush injury134. In one mouse study the dose came before the injury instead: mice given BPC-157 30 minutes before a head injury, or just before it, had fewer deaths and less brain damage than untreated mice7.
Neither design tells you whether a dose before a training session beats one after it. A workout is not a cut tendon, and in the rats and dogs whose blood was measured, a dose was gone within 4 hours8, so a dose before a session and one after it would both be cleared within hours of each other. Training timing is, for now, a habit people choose rather than a finding.
Does BPC-157 need to be taken on an empty stomach?
For injections there is no reason in the studies to think food matters, and no study has looked. For BPC-157 by mouth, the rat studies dissolved it in drinking water, so the animals took it in sips with their normal food all day and still healed better25. How much of a swallowed dose reaches the blood (its bioavailability, see pepvault.app/glossary/bioavailability) has not been measured in any published study12.
Only one study was ever designed to answer the food question: the 2015 tablet trial kept volunteers fasting around their first dose and gave one group a second dose after a meal13. It has posted no results, and the FDA's July 2026 review could find no published paper from it12. How the routes compare is in our guide at pepvault.app/guides/bpc-157-oral-nasal-injected.
How soon after an injury, and for how long, did studies give BPC-157?
In rats, soon and for the whole healing period. The tendon, ligament and muscle studies started 30 minutes after the injury or straight after it, and kept going once a day to the end of the study: 14 days for the tendon1 and the crushed muscle4, 72 days for the cut thigh muscle3, and 90 days for the ligament2. The repeat-dose safety study in animals ran 28 days of daily injections in rats and dogs, then 14 days off12.
In people, most of the record is a single treatment: one procedure in the bladder10, one or two knee injections912, two infusions on two days11. The first controlled trial of daily injections under the skin, after shoulder surgery at the University of Arkansas, plans 90 days and is set to start in January 202714. How soon users say it works is at pepvault.app/peptides/bpc-157/how-long-to-work.
When to get help An injury that keeps getting worse, or an injection site that turns hot, swollen and more painful each day, is a reason to see a doctor.
What timing do people who use BPC-157 report?
Commonly reported: one dose a day at a fixed time, or the day's amount split between morning and evening; oral users often take it on an empty stomach; tendon and ligament pain easing within one to three weeks.
These are user habits, not study results. The pattern that holds in the studies is simpler: a daily dose, started near the injury and kept up through the healing period. Every human study we found is at pepvault.app/guides/bpc-157-human-data, and the compound's full page is pepvault.app/peptides/bpc-157.
Each dose in PepVault's log keeps the time you took it, and a twice-daily schedule logs each dose on its own, so you can see whether your timing changed anything over the weeks. Log it in PepVault
Sources
- Staresinic M et al. Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth. J Orthop Res. 2003. PubMed 14554208
- Cerovecki T et al. Pentadecapeptide BPC 157 (PL 14736) improves ligament healing in the rat. J Orthop Res. 2010. PubMed 20225319
- Staresinic M et al. Effective therapy of transected quadriceps muscle in rat: gastric pentadecapeptide BPC 157. J Orthop Res. 2006. PubMed 16609979
- Novinscak T et al. Gastric pentadecapeptide BPC 157 as an effective therapy for muscle crush injury in the rat. Surg Today. 2008. PubMed 18668315
- Japjec M et al. Stable gastric pentadecapeptide BPC 157 as a therapy for the disable myotendinous junctions in rats. Biomedicines. 2021. PubMed 34829776
- Ilic S et al. Pentadecapeptide BPC 157 and its effects on a NSAID toxicity model: diclofenac-induced gastrointestinal, liver, and encephalopathy lesions. Life Sci. 2011. PubMed 21295044
- Tudor M et al. Traumatic brain injury in mice and pentadecapeptide BPC 157 effect. Regul Pept. 2010. PubMed 19931318
- He L et al. Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs. Front Pharmacol. 2022. PubMed 36588717
- Lee E, Padgett B. Intra-articular injection of BPC 157 for multiple types of knee pain. Altern Ther Health Med. 2021. PubMed 34324435
- Lee E, Walker C, Ayadi B. Effect of BPC-157 on symptoms in patients with interstitial cystitis: a pilot study. Altern Ther Health Med. 2024. PubMed 39325560
- Lee E, Burgess K. Safety of intravenous infusion of BPC157 in humans: a pilot study. Altern Ther Health Med. 2025. PubMed 40131143
- U.S. Food and Drug Administration. Briefing document for BPC-157-related bulk drug substances, Pharmacy Compounding Advisory Committee meeting, July 23-24, 2026. fda.gov
- ClinicalTrials.gov NCT02637284. PCO-02: safety and pharmacokinetics trial. PharmaCotherapia. clinicaltrials.gov
- ClinicalTrials.gov NCT07803250. Impact of BPC-157 on recovery following rotator cuff repair surgery. University of Arkansas. clinicaltrials.gov
- ClinicalTrials.gov NCT07752381. A clinical trial to evaluate the effects of peptide gummies on markers of inflammation, physical performance, and recovery. clinicaltrials.gov
Newsletter · Weekly
The weekly peptide briefing.
New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.